Klaria Pharma Shares Owned By Institutions vs. Shares Outstanding
| KLAR Stock | SEK 0.35 0.01 2.78% |
For Klaria Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Klaria Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Klaria Pharma Holding utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Klaria Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Klaria Pharma Holding over time as well as its relative position and ranking within its peers.
Klaria |
Klaria Pharma Holding Shares Outstanding vs. Shares Owned By Institutions Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Klaria Pharma's current stock value. Our valuation model uses many indicators to compare Klaria Pharma value to that of its competitors to determine the firm's financial worth. Klaria Pharma Holding is currently regarded as number one stock in shares owned by institutions category among its peers. It also is currently regarded as number one stock in shares outstanding category among its peers creating about 6,471,754 of Shares Outstanding per Shares Owned By Institutions. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Klaria Pharma's earnings, one of the primary drivers of an investment's value.Klaria Shares Outstanding vs. Shares Owned By Institutions
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Klaria Pharma |
| = | 9.75 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Klaria Pharma |
| = | 63.1 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Klaria Shares Outstanding Comparison
Klaria Pharma is currently under evaluation in shares outstanding category among its peers.
Klaria Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Klaria Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Klaria Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Klaria Pharma's change in net profit over the period of time. It can combine multiple indicators of Klaria Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Klaria Pharma Holding AB develops treatment methods in the therapeutic fields of migraine and pain related to cancer worldwide. Klaria Pharma Holding AB was founded in 2014 and is based in Uppsala, Sweden. Klaria Pharma is traded on Stockholm Stock Exchange in Sweden.
Klaria Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Klaria Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Klaria Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Klaria Pharma's important profitability drivers and their relationship over time.
Use Klaria Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Klaria Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klaria Pharma will appreciate offsetting losses from the drop in the long position's value.Klaria Pharma Pair Trading
Klaria Pharma Holding Pair Trading Analysis
The ability to find closely correlated positions to Klaria Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klaria Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klaria Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Klaria Pharma Holding to buy it.
The correlation of Klaria Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Klaria Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Klaria Pharma Holding moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Klaria Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Klaria Pharma position
In addition to having Klaria Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run World Allocation Funds Thematic Idea Now
World Allocation Funds
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Klaria Stock Analysis
When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.